Shefali Shah, MD
Gastroenterology · Oakhurst, NJNPI 1720469950
Payments from drug & device makers
Across 274 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Madrigal Pharmaceuticals$601
- Johnson & Johnson$563
- QOL Medical, LLC$477
- Takeda Pharmaceuticals U.S.A., Inc.$429
- Pfizer$414
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$200%
- Grants$200%
- Food & beverage$5,23697%
- Education$1162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,047 |
| Madrigal Pharmaceuticals | 29 | $601 |
| Johnson & Johnson | 26 | $563 |
| QOL Medical, LLC | 28 | $477 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $429 |
| Pfizer | 24 | $414 |
| Sanofi | 19 | $370 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $196 |
| Regeneron Healthcare Solutions, Inc. | 10 | $175 |
| Davol Inc. | 1 | $150 |
| Covidien LP | 1 | $125 |
| Medtronic | 2 | $117 |
| Merck | 6 | $93 |
| Lilly USA, LLC | 4 | $82 |
| Bristol Myers Squibb | 5 | $71 |
| Daiichi Sankyo Inc. | 4 | $60 |
| Ipsen Biopharmaceuticals, Inc | 3 | $54 |
| Ironwood Pharmaceuticals, Inc | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 5 | $35 |
| Vivus LLC | 2 | $33 |
| GSK | 2 | $31 |
| Ardelyx, Inc. | 2 | $28 |
| Olympus America Inc. | 2 | $27 |
| Gilead | 1 | $26 |
| Capsovision, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Intra-sana Laboratories | 1 | $14 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$250
- Phasix Mesh$150
- REZDIFFRA$142
- Barrx$125
- Skyrizi$125
How this compares
$5,392 in reported general payments places this provider in the 70th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 37 | $2,272 |
| Omeprazole | 85 | $1,466 |
| Pantoprazole Sodium | 74 | $670 |
| Sucralfate | 16 | $658 |
| Famotidine | 38 | $451 |
| Lactulose | 13 | $289 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $172 |
| Ibuprofen | 11 | $143 |
| Hydrocortisone | 20 | $138 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Oakhurst
- Kiran RaoSparta$1.3M
- Adekunle AdeotiIrvington$1.2M
- Carl WallachMorristown$766K
- Vinod RustgiNew Brunswick$697K
- Arvind TrindadeNew Brunswick$652K
- Barry KaufmanEgg Harbor Township$595K
- Promila BanerjeeStratford$522K
- Neil NagariaToms River$442K
- Zamir BrelviNewark$408K
- Adam ElfantMount Laurel$385K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.